Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion
Primary Purpose
Dry Eye
Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Systane Balance Lubricating Eye Drops
OPTIVE™
Sponsored by
About this trial
This is an interventional basic science trial for Dry Eye focused on measuring Ocular Emulsion, OPTIVE™ Lubricant, Tear Film Break Up Time
Eligibility Criteria
Inclusion Criteria:
- The subject must be 18 years of age or older;
- The subject must have a best corrected visual acuity of 0.6 LogMAR (~6/24) or better in each eye
- The subject must not have used any topical ocular drops for approximately 24 hours prior to the enrolment/screening visit
The subject must be classified as dry eye at enrolment/screening visit according to the following criteria:
- Subjects' self-assessment of dry eye status (answer of at least "some of the time" to the question, "How often have your eyes felt dry enough to want to use eye drops?");
- TFBUT measured with DET ≤ 5 seconds in at least one eye;
- Grade 1 for meibomian gland expression in both eyes;
- Evidence of missing meibomian glands in both eyes.
Exclusion Criteria:
- History or evidence of ocular or intraocular surgery in either eye within the past six months.
- History or evidence of serious ocular trauma in either eye within the past six months.
- Current punctal occlusion of any type (e.g., collagen plugs, silicone plugs).
- History or evidence of epithelial herpes simplex keratitis (dendritic keratitis); vaccinia; active or recent varicella viral disease of the cornea and/or conjunctiva; chronic bacterial disease of the cornea and/or conjunctiva and/or eyelids; mycobacterial infection of the eye; and/or fungal disease of the eye.
- Use of any concomitant topical ocular medications during the study period.
- Ocular conditions such as conjunctival infections, iritis, or any other ocular condition that may preclude the safe administration of either drop under investigation.
- Participation in an investigational drug or device study within 30 days of entering this study.
Sites / Locations
- Contact Alcon Call Center for Trial Locations
- OTG Research & Consultancy
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Ocular Emulsion
OPTIVE™
Arm Description
An Ocular Emulsion
An OPTIVE™
Outcomes
Primary Outcome Measures
Measurement of the tear film break-up time using DET sodium fluorescein strips.
Secondary Outcome Measures
Measurement of the tear film break-up time in a non invasive manner using the Tearscope®. Measurement of the tear film break-up time in a non invasive manner using the Tearscope®.
Full Information
NCT ID
NCT01368198
First Posted
May 6, 2011
Last Updated
January 31, 2012
Sponsor
Alcon Research
Collaborators
Optometric Technology Group Ltd
1. Study Identification
Unique Protocol Identification Number
NCT01368198
Brief Title
Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion
Official Title
The Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion
Study Type
Interventional
2. Study Status
Record Verification Date
January 2012
Overall Recruitment Status
Completed
Study Start Date
March 2011 (undefined)
Primary Completion Date
June 2011 (Actual)
Study Completion Date
June 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Alcon Research
Collaborators
Optometric Technology Group Ltd
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The primary objective of this investigation will be to quantify the increase in tear film break-up time (TFBUT) associated with the instillation of a single eyedrop of an Ocular Emulsion in dry eye sufferers.
Detailed Description
The secondary objective of this investigation will be to compare the tear film break up time measured with two different techniques.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dry Eye
Keywords
Ocular Emulsion, OPTIVE™ Lubricant, Tear Film Break Up Time
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Ocular Emulsion
Arm Type
Active Comparator
Arm Description
An Ocular Emulsion
Arm Title
OPTIVE™
Arm Type
Active Comparator
Arm Description
An OPTIVE™
Intervention Type
Other
Intervention Name(s)
Systane Balance Lubricating Eye Drops
Other Intervention Name(s)
Ocular Emulsion
Intervention Description
One instillation of the eye drop in each eye
Intervention Type
Other
Intervention Name(s)
OPTIVE™
Other Intervention Name(s)
Optive
Intervention Description
One instillation of the eye drop in each eye
Primary Outcome Measure Information:
Title
Measurement of the tear film break-up time using DET sodium fluorescein strips.
Time Frame
Enrollment Test visit 1
Secondary Outcome Measure Information:
Title
Measurement of the tear film break-up time in a non invasive manner using the Tearscope®. Measurement of the tear film break-up time in a non invasive manner using the Tearscope®.
Time Frame
Enrollment Test visit 2
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
The subject must be 18 years of age or older;
The subject must have a best corrected visual acuity of 0.6 LogMAR (~6/24) or better in each eye
The subject must not have used any topical ocular drops for approximately 24 hours prior to the enrolment/screening visit
The subject must be classified as dry eye at enrolment/screening visit according to the following criteria:
Subjects' self-assessment of dry eye status (answer of at least "some of the time" to the question, "How often have your eyes felt dry enough to want to use eye drops?");
TFBUT measured with DET ≤ 5 seconds in at least one eye;
Grade 1 for meibomian gland expression in both eyes;
Evidence of missing meibomian glands in both eyes.
Exclusion Criteria:
History or evidence of ocular or intraocular surgery in either eye within the past six months.
History or evidence of serious ocular trauma in either eye within the past six months.
Current punctal occlusion of any type (e.g., collagen plugs, silicone plugs).
History or evidence of epithelial herpes simplex keratitis (dendritic keratitis); vaccinia; active or recent varicella viral disease of the cornea and/or conjunctiva; chronic bacterial disease of the cornea and/or conjunctiva and/or eyelids; mycobacterial infection of the eye; and/or fungal disease of the eye.
Use of any concomitant topical ocular medications during the study period.
Ocular conditions such as conjunctival infections, iritis, or any other ocular condition that may preclude the safe administration of either drop under investigation.
Participation in an investigational drug or device study within 30 days of entering this study.
Facility Information:
Facility Name
Contact Alcon Call Center for Trial Locations
City
Fort Worth
State/Province
Texas
ZIP/Postal Code
76134
Country
United States
Facility Name
OTG Research & Consultancy
City
London
State/Province
England
ZIP/Postal Code
SW1E 6AU
Country
United Kingdom
12. IPD Sharing Statement
Learn more about this trial
Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion
We'll reach out to this number within 24 hrs